Sidman, Richard L; Li, Jianxue; Lawrence, Matthew; Hu, Wenzheng; Musso, Gary F; Giordano, Ricardo José 
; Cardó-Vila, Marina; Pasqualini, Renata; Arap, Wadih
Source: Science Translational Medicine. Unidade: IQ
Subjects: DOENÇAS RETINIANAS, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIDMAN, Richard L et al. The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease. Science Translational Medicine, v. 7, p. 1-15 art. 309, 2015Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.aac4882. Acesso em: 10 nov. 2024.APA
Sidman, R. L., Li, J., Lawrence, M., Hu, W., Musso, G. F., Giordano, R. J., et al. (2015). The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease. Science Translational Medicine, 7, 1-15 art. 309. doi:10.1126/scitranslmed.aac4882NLM
Sidman RL, Li J, Lawrence M, Hu W, Musso GF, Giordano RJ, Cardó-Vila M, Pasqualini R, Arap W. The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease [Internet]. Science Translational Medicine. 2015 ; 7 1-15 art. 309.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1126/scitranslmed.aac4882Vancouver
Sidman RL, Li J, Lawrence M, Hu W, Musso GF, Giordano RJ, Cardó-Vila M, Pasqualini R, Arap W. The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease [Internet]. Science Translational Medicine. 2015 ; 7 1-15 art. 309.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1126/scitranslmed.aac4882
